Alembic Pharma: Healthy growth story
Increased R&D spend should boost revenue over the long term
Alembic Pharma is attractively placed to deliver sustainable growth over the long haul, given its strong US business, focus on domestic speciality segment and commitment towards developing a long-term product pipeline through proactive investments in research and business.Investors with a three- to five-year time horizon can consider buying the stock. The stock is down 12 per cent from its Septemb...
Read the rest of this article by Signing up for Portfolio.
It's completely free!
SIGN UP NOW
Investment alerts,End of day market reports, Market news analysis,External research reports and Technical calls
Daily update on Business and Market news via email
'Your Market Corner' Widget with personalized business and market news